BRISTOL MYERS SQUIBB CO (BMY) Options Risk Score
Real-time risk analysis for BMY options traders — updated every 30 minutes.
Data last updated: 2026-07-23
Run a full BMY options risk analysis
See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.
Scan BMY Now — Free →
Is it risky to sell options on BRISTOL MYERS SQUIBB CO (BMY) right now?
For a 4-week expiry, BRISTOL MYERS SQUIBB CO (BMY) carries an options catalyst-risk score of 48 out of 100 (MEDIUM). That score is driven by 6 active legal filings and 29 clinical-trial catalysts falling inside the 4-week window. MEDIUM covers 45 to 69: there is something on BMY's calendar worth reading before you pick an expiry, without it dominating the trade. Direction is not part of what the score measures.
BMY shows an IV Rank of 77 — implied volatility is near the top of its own one-year range, so BMY options are historically expensive, which favours premium-selling strategies, with a current implied volatility of about 36%. IV Rank is the most useful figure for deciding whether to sell or buy premium on BMY.
BMY does not report again until 2026-07-30, so near-dated expiries avoid it.
TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer